CN101099831A - 一种治疗小儿癫痫的中药组合物及其制备方法 - Google Patents
一种治疗小儿癫痫的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN101099831A CN101099831A CN 200610089579 CN200610089579A CN101099831A CN 101099831 A CN101099831 A CN 101099831A CN 200610089579 CN200610089579 CN 200610089579 CN 200610089579 A CN200610089579 A CN 200610089579A CN 101099831 A CN101099831 A CN 101099831A
- Authority
- CN
- China
- Prior art keywords
- rhizoma
- bran
- parched
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010015037 epilepsy Diseases 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- 239000000203 mixture Substances 0.000 title claims description 35
- 239000003814 drug Substances 0.000 claims abstract description 40
- 241000489492 Arisaema Species 0.000 claims abstract description 15
- 210000000941 bile Anatomy 0.000 claims abstract description 15
- 241000242759 Actiniaria Species 0.000 claims description 14
- 241000675108 Citrus tangerina Species 0.000 claims description 14
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 14
- 239000010271 massa medicata fermentata Substances 0.000 claims description 14
- 239000000843 powder Substances 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 10
- 239000002775 capsule Substances 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 8
- 239000008187 granular material Substances 0.000 claims description 8
- 239000004615 ingredient Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 5
- 239000003826 tablet Substances 0.000 claims description 5
- 239000003937 drug carrier Substances 0.000 claims description 4
- 239000007901 soft capsule Substances 0.000 claims description 4
- 239000006196 drop Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 2
- 238000010992 reflux Methods 0.000 claims description 2
- 244000001632 Acorus gramineus Species 0.000 abstract 1
- 235000013073 Acorus gramineus Nutrition 0.000 abstract 1
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 244000012254 Canarium album Species 0.000 abstract 1
- 235000009103 Canarium album Nutrition 0.000 abstract 1
- MCTQNEBFZMBRSQ-GEEYTBSJSA-N Chrysoidine Chemical compound Cl.NC1=CC(N)=CC=C1\N=N\C1=CC=CC=C1 MCTQNEBFZMBRSQ-GEEYTBSJSA-N 0.000 abstract 1
- 241000510667 Conioselinum Species 0.000 abstract 1
- 241000305491 Gastrodia elata Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 241001522129 Pinellia Species 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 241001038563 Pseudostellaria Species 0.000 abstract 1
- 239000010135 fructus aurantii immaturus Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 20
- 206010010904 Convulsion Diseases 0.000 description 14
- 206010062717 Increased upper airway secretion Diseases 0.000 description 12
- 208000026435 phlegm Diseases 0.000 description 12
- 208000011580 syndromic disease Diseases 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 230000036461 convulsion Effects 0.000 description 6
- 239000003172 expectorant agent Substances 0.000 description 6
- 230000003419 expectorant effect Effects 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 208000034308 Grand mal convulsion Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 3
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 3
- 208000021760 high fever Diseases 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000003925 brain function Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 210000003754 fetus Anatomy 0.000 description 2
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 2
- 229960002695 phenobarbital Drugs 0.000 description 2
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000005550 wet granulation Methods 0.000 description 2
- 235000019890 Amylum Nutrition 0.000 description 1
- 206010049612 Autonomic seizure Diseases 0.000 description 1
- 208000001654 Drug Resistant Epilepsy Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010013887 Dysarthria Diseases 0.000 description 1
- 208000024658 Epilepsy syndrome Diseases 0.000 description 1
- 208000002877 Epileptic Syndromes Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 description 1
- 108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 description 1
- CWRVKFFCRWGWCS-UHFFFAOYSA-N Pentrazole Chemical compound C1CCCCC2=NN=NN21 CWRVKFFCRWGWCS-UHFFFAOYSA-N 0.000 description 1
- 206010034759 Petit mal epilepsy Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- QWCKQJZIFLGMSD-UHFFFAOYSA-N alpha-aminobutyric acid Chemical class CCC(N)C(O)=O QWCKQJZIFLGMSD-UHFFFAOYSA-N 0.000 description 1
- 230000003556 anti-epileptic effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000007766 cera flava Substances 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- NIJJYAXOARWZEE-UHFFFAOYSA-N di-n-propyl-acetic acid Natural products CCCC(C(O)=O)CCC NIJJYAXOARWZEE-UHFFFAOYSA-N 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 229960005152 pentetrazol Drugs 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 229960002790 phenytoin sodium Drugs 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229960002393 primidone Drugs 0.000 description 1
- DQMZLTXERSFNPB-UHFFFAOYSA-N primidone Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NCNC1=O DQMZLTXERSFNPB-UHFFFAOYSA-N 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 208000026473 slurred speech Diseases 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229940084026 sodium valproate Drugs 0.000 description 1
- AEQFSUDEHCCHBT-UHFFFAOYSA-M sodium valproate Chemical compound [Na+].CCCC(C([O-])=O)CCC AEQFSUDEHCCHBT-UHFFFAOYSA-M 0.000 description 1
- FJPYVLNWWICYDW-UHFFFAOYSA-M sodium;5,5-diphenylimidazolidin-1-ide-2,4-dione Chemical compound [Na+].O=C1[N-]C(=O)NC1(C=1C=CC=CC=1)C1=CC=CC=C1 FJPYVLNWWICYDW-UHFFFAOYSA-M 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 208000028325 tonic-clonic seizure Diseases 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200610089579 CN100548351C (zh) | 2006-07-04 | 2006-07-04 | 一种治疗小儿癫痫的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200610089579 CN100548351C (zh) | 2006-07-04 | 2006-07-04 | 一种治疗小儿癫痫的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101099831A true CN101099831A (zh) | 2008-01-09 |
CN100548351C CN100548351C (zh) | 2009-10-14 |
Family
ID=39034384
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200610089579 Active CN100548351C (zh) | 2006-07-04 | 2006-07-04 | 一种治疗小儿癫痫的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100548351C (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102935167A (zh) * | 2012-11-23 | 2013-02-20 | 刘永俊 | 一种治疗腹型癫痫综合征的中药 |
CN103285212A (zh) * | 2013-05-29 | 2013-09-11 | 王智霞 | 一种治疗小儿癫痫的中药制剂及其制备方法 |
CN103961538A (zh) * | 2014-05-08 | 2014-08-06 | 薛冬梅 | 一种治疗发作期风痫型小儿癫痫的中药组合物 |
CN104189321A (zh) * | 2014-08-19 | 2014-12-10 | 李新民 | 一种治疗癫痫的配方 |
CN115350248A (zh) * | 2022-09-29 | 2022-11-18 | 常州市金坛第一人民医院 | 神经内科的用于治疗癫痫的中药药物 |
-
2006
- 2006-07-04 CN CN 200610089579 patent/CN100548351C/zh active Active
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102935167A (zh) * | 2012-11-23 | 2013-02-20 | 刘永俊 | 一种治疗腹型癫痫综合征的中药 |
CN102935167B (zh) * | 2012-11-23 | 2013-10-09 | 刘永俊 | 一种治疗腹型癫痫综合征的中药 |
CN103285212A (zh) * | 2013-05-29 | 2013-09-11 | 王智霞 | 一种治疗小儿癫痫的中药制剂及其制备方法 |
CN103285212B (zh) * | 2013-05-29 | 2014-09-17 | 王智霞 | 一种治疗小儿癫痫的中药制剂及其制备方法 |
CN103961538A (zh) * | 2014-05-08 | 2014-08-06 | 薛冬梅 | 一种治疗发作期风痫型小儿癫痫的中药组合物 |
CN103961538B (zh) * | 2014-05-08 | 2016-07-06 | 王淑军 | 一种治疗发作期风痫型小儿癫痫的中药组合物 |
CN104189321A (zh) * | 2014-08-19 | 2014-12-10 | 李新民 | 一种治疗癫痫的配方 |
CN115350248A (zh) * | 2022-09-29 | 2022-11-18 | 常州市金坛第一人民医院 | 神经内科的用于治疗癫痫的中药药物 |
CN115350248B (zh) * | 2022-09-29 | 2024-01-30 | 常州市金坛第一人民医院 | 神经内科的用于治疗癫痫的中药药物 |
Also Published As
Publication number | Publication date |
---|---|
CN100548351C (zh) | 2009-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101019975A (zh) | 一种治疗骨折的中药组合物及其制备方法 | |
CN101450122A (zh) | 一种治疗失眠的中药制剂和制备方法及其应用 | |
CN100548351C (zh) | 一种治疗小儿癫痫的中药组合物及其制备方法 | |
CN101185733A (zh) | 一种健胃消食口腔崩解片及制备方法 | |
CN101856405B (zh) | 一种治疗2型糖尿病的药物组合物及其制备方法 | |
CN114470114A (zh) | 脉络舒通制剂在制备治疗便秘药物中的应用 | |
CN102204602B (zh) | 一种降脂、降压保健茶及其制备方法 | |
CN1205974C (zh) | 一种治疗糖尿病的药物组合物 | |
CN101496889A (zh) | 一种用于定志安神、舒肝解郁的中药组合及其制备方法 | |
CN101703691A (zh) | 一种治疗消化道溃疡、出血的中药组合物及其制备方法 | |
AU2021106260A4 (en) | A Traditional Chinese Medicine Composition With Preparation Method And Application Thereof | |
CN102423435A (zh) | 治疗小儿疳积症的中药及其制备方法 | |
CN103520646A (zh) | 一种治疗抑郁症的中药组合物及其制备方法 | |
CN103356939A (zh) | 一种治疗遗尿的药物及其制备方法 | |
CN105769957A (zh) | 一种雪梨米泔水制三七粉及其制剂和制备方法 | |
CA2422973A1 (en) | Health food for good sleep | |
CN1270737C (zh) | 治疗痛风的丸剂及制备方法 | |
CN101401853B (zh) | 一种治疗烧伤、烫伤的药物组合物及其制备方法 | |
CN100471519C (zh) | 一种治疗胃病的药物组合物及其制备方法和用途 | |
WO2022120906A1 (zh) | 一种具有抗焦虑作用的中药复方组合物及其制备方法与应用 | |
CN106616931A (zh) | 一种食用菌组合物及应用 | |
CN108669530A (zh) | 一种利于肠胃健康的猴头菇组合物、片剂及制备方法 | |
CN102139016A (zh) | 一种用于治疗慢性胃炎的枸杞漂浮片及其制备方法 | |
CN103877230A (zh) | 一种用于预防和/或治疗老年痴呆症的药物提取物及其制备方法、制剂和应用 | |
CN103083488A (zh) | 一种用于治疗骨病的中药组合物及其制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HEBEI ZHAOKANG PHARMACY CO., LTD. Free format text: FORMER OWNER: LAN YUQI Effective date: 20101124 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 064400 LONGSHAN MEDICINE CO., LTD., TANGSHAN CITY, EAST OF FENG'AN ROAD, QIAN'AN CITY, HEBEI PROVINCE TO: 064400 NO.188, ZHAOKANG STREET, QIAN'AN CITY, HEBEI PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20101124 Address after: 064400, 188, Siu Kang Street, Qian'an, Hebei Patentee after: Hebei Zhaokang Pharmacy Co.,Ltd. Address before: 064400 Tangshan City Longshan Pharmaceutical Industry Co., Ltd., Hebei, Qian'an Province Patentee before: Lanyuqi |
|
ASS | Succession or assignment of patent right |
Owner name: HAN ZHIQIANG Free format text: FORMER OWNER: HEBEI ZHAOKANG PHARMACY CO., LTD. Effective date: 20110908 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 064400 TANGSHAN, HEBEI PROVINCE TO: 063000 TANGSHAN, HEBEI PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20110908 Address after: 063000 Hebei Province, Tangshan City Road north of Dali Zhang Lai Kam Park D block 2 Gate 702. Patentee after: Han Zhiqiang Address before: 064400, 188, Siu Kang Street, Qian'an, Hebei Patentee before: Hebei Zhaokang Pharmacy Co.,Ltd. |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20080109 Assignee: Hebei Baishan Pharmaceutical Co.,Ltd. Assignor: Han Zhiqiang Contract record no.: 2015990000119 Denomination of invention: Traditional Chinese medicinal composition for treating children epilepsy and its preparation method Granted publication date: 20091014 License type: Common License Record date: 20150323 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20161018 Address after: 063000 Hebei Province, Tangshan City Road north of Dali Zhang Lai Kam Park D block 2 Gate 702. Patentee after: Han Zhiqiang Patentee after: Hebei Baishan Pharmaceutical Co.,Ltd. Address before: 063000 Hebei Province, Tangshan City Road north of Dali Zhang Lai Kam Park D block 2 Gate 702. Patentee before: Han Zhiqiang |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Traditional Chinese medicinal composition for treating children epilepsy and its preparation method Effective date of registration: 20170216 Granted publication date: 20091014 Pledgee: Bank of Cangzhou Limited by Share Ltd. Tangshan branch Pledgor: Hebei Baishan Pharmaceutical Co.,Ltd.|Han Zhiqiang Registration number: 2017990000108 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20180124 Granted publication date: 20091014 Pledgee: Bank of Cangzhou Limited by Share Ltd. Tangshan branch Pledgor: Hebei Baishan Pharmaceutical Co.,Ltd.|Han Zhiqiang Registration number: 2017990000108 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Traditional Chinese medicinal composition for treating children epilepsy and its preparation method Effective date of registration: 20180124 Granted publication date: 20091014 Pledgee: Bank of Cangzhou Limited by Share Ltd. Tangshan branch Pledgor: Han Zhiqiang|Hebei Baishan Pharmaceutical Co.,Ltd. Registration number: 2018990000081 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190111 Granted publication date: 20091014 Pledgee: Bank of Cangzhou Limited by Share Ltd. Tangshan branch Pledgor: Han Zhiqiang|Hebei Baishan Pharmaceutical Co.,Ltd. Registration number: 2018990000081 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Traditional Chinese medicinal composition for treating children epilepsy and its preparation method Effective date of registration: 20190111 Granted publication date: 20091014 Pledgee: Bank of Cangzhou Limited by Share Ltd. Tangshan branch Pledgor: Han Zhiqiang|Hebei Baishan Pharmaceutical Co.,Ltd. Registration number: 2019990000032 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230808 Granted publication date: 20091014 Pledgee: Bank of Cangzhou Limited by Share Ltd. Tangshan branch Pledgor: Han Zhiqiang|Hebei Baishan Pharmaceutical Co.,Ltd. Registration number: 2019990000032 |